Green MJ, McInerney AM, Biesecker BB, Fost N (2001) Education about genetic testing for breast cancer susceptibility: patient preferences for a computer program or genetic counselor. Am J Med Genet 103:24–31Green, M. J., McInerney, A. M., Biesecker, B. B., & Fost, N. (2001b...
Most women know about mammograms for early detection of breast cancer. The BRCA1 and BRCA2 genetic tests are much less widely known. Dr. Douglas E.
Two separate dependent variables were used as measures for intention to obtain BRCA testing: (1) "I plan to have a genetic test for breast cancer only if my insurance covers the cost"; and (2) "I plan to have a genetic test for breast cancer, even if I have to pay for it myself...
“The more I can normalize genetic testing, the more lives we can save,” she said.At age 19, Kinsey tested positive for the BRCA1 gene mutation. A BRCA (breast cancer) gene mutation increases a person’s risk for developing several types of cancer, primarily breast cancer and ovarian ...
Targeted genetic testing is a tool to identify women at increased risk of gynaecological cancer.Objective: This systematic review evaluates the results and quality of cost-effectiveness modeling studies that assessedtargeted genetic-based screen-and-treat strategies to prevent breast and ovarian cancer.Met...
chemotherapy costs of $2.701 billion and Oncotype DX testing costs estimated to be $115 million, for a total healthcare cost of $2.816 billion in the first year after diagnosis. The researchers estimated that only 34.8 to 57.2 percent of women were receiving the Oncotype DX testing in this pe...
Patients with a higher likelihood to develop BRCA 1 or BRCA 2 mutations are slipping through the cracks, making testing for these mutations a vital part of any breast cancer treatment plan.
Genetic testing guidelines for breast cancer are out-of-date and miss nearly half of patients diagnosed with the malignancy, doctors found in a new analysis of who gets tested and who doesn't. Health insurance companies and government payers base how they reimburse patients for tests and procedur...
To examine the relative cost-effectiveness of predictive genetic tests for familial breast and ovarian cancer provided by Genetic Services of Western Australia. The relative cost-effectiveness was assessed using a decision analytic model. The cost and outcomes of genetic testing was compared in first-...
GENERAL ISSUES IN BREAST CANCER Cost of Genetic Counseling and Testing for BRCA1 and BRCA2 Breast Cancer Susceptibility Mutations... WF Lawrence,BN Peshkin,W Liang - 《Breast Diseases》 被引量: 0发表: 2002年 BRCAPRO validation, sensitivity of genetic testing of BRCA1/BRCA2, and prevalence ...